THE LEVEL OF sPECAM-1 DURING SYSTEMIC OZONE THERAPY
Systemic ozone therapy used during combination treatment shows a significant reduction in the titer of soluble platelet endothelial cell adhesion molecule-1 (sPECAM-1) in the peripheral plasma of patients with local cold injury and arterosclerosis obliterans of the lower extremities.